Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Julie Carlisle has worked on the following 46 EPO patent applications which have been published in the last five years:

EP11751256

MOLECULARLY IMPRINTED CARBON

IPC classification:
C01B 31/02
Applicant:
The Ohio State University Research Foundation
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11760242

COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORT INHIBITION

IPC classification:
A01N 31/00, A61K 31/045
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11843945

INTEGRIN-LINKED KINASE INHIBITORS

IPC classification:
A01N 43/56, A61K 31/415
Applicant:
The Ohio State University Research Foundation
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13175481

Process for producing substituted methylamine compound and triazine derivative

IPC classification:
C07B 43/04, C07D 213/61, C07D 401/06, C07D 401/14
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13175480

Process for producing substituted methylamine compound and triazine derivative

IPC classification:
C07B 43/04, C07D 213/61, C07D 401/06, C07D 401/14
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13174255

Plant disease control agent

IPC classification:
A01N 37/34, A01N 37/46, A01N 43/36, A01N 43/50, A01N 43/54, A01N 43/653, A01N 43/713, A01N 47/04, A01N 47/12, A01N 47/18, A01N 47/34, A01N 47/44, A01N 51/00, A01N 55/02, A01N 57/12, A01N 59/20, A01P 3/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP12749942

USE OF TEMPLATE SWITCHING FOR DNA SYNTHESIS

IPC classification:
C12N 15/10, C12Q 1/68
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12760881

AQUEOUS HORTICULTURAL MICROBICIDAL COMPOSITION SUSPENSION

IPC classification:
A01N 25/04, A01N 25/30, A01N 43/713, A01P 3/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12781697

LIQUID INSECTICIDE COMPOSITION

IPC classification:
A01N 25/02, A01N 25/30, A01N 47/40, A01P 7/04
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12815454

RUTHENIUM CARBON MONOXIDE RELEASING MOLECULES AND USES THEREOF

IPC classification:
A01N 55/02, A01N 59/04, A61K 39/40
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11821298

RECORDING MATERIAL USING PHENOL COMPOUND

IPC classification:
B41M 5/155, B41M 5/333, C07C 231/02, C07C 233/07, C07C 233/11
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11838597

ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES

IPC classification:
A61K 31/415, A61K 31/4155, A61K 31/5415, A61P 31/04, C07D 231/12, C07D 405/04, C07D 471/04
Applicant:
The Ohio State University Research Foundation
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11800415

NOVEL COPOLYMER

IPC classification:
B01F 17/16, B01F 17/18, B01F 17/52, C08F 297/02, C09D 11/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12836312

METHOD FOR PRODUCING ELECTRODE COVERED WITH SODIUM METAL

IPC classification:
C23C 2/04, C23C 14/14, C23C 26/00, H01M 4/134, H01M 4/1395
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12838482

SILYLATED POLYBUTADIENE

IPC classification:
C08F 8/00, C08F 36/06, C08K 5/14, C08L 47/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12834802

INTACT MASS DETERMINATION OF PROTEIN CONJUGATED AGENT COMPOUNDS

IPC classification:
G01N 24/00
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12841303

NOVEL COPOLYMER

IPC classification:
C08F 297/02, C09B 67/20, G02B 5/20
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12175020

Method for identifying pI3-kinase antagonists

IPC classification:
A61K 31/519, A61P 35/00, A61P 35/04, C07D 487/04
Applicant:
The Regents of the University of California
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12850965

PHOTOCATALYST-SUPPORTING STRUCTURE

IPC classification:
B01J 35/02, B32B 7/12, B32B 9/00, B32B 27/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11705962

METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF 4-OXO-3,4-DIHYDRO-IMIDAZO[5,1-D][1,2,3,5]TETRAZINES

IPC classification:
C07D 487/04
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13782216

DR5 LIGAND DRUG CONJUGATES

IPC classification:
A61K 39/395
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14182732

Auristatin drug linker conjugates

IPC classification:
A61K 38/00, A61K 47/48, C07K 5/02
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14185157

Thioninium compounds and their use

IPC classification:
A61K 31/5415, A61P 25/28
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13804801

METHOD FOR PRODUCING AZIDE COMPOUND, AND METHOD FOR PRODUCING 1H-TETRAZOLE DERIVATIVE

IPC classification:
C07C 247/04, C07D 257/04
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13813323

COMPOSITION CONTAINING BIOLOGICALLY ACTIVE SUBSTANCE

IPC classification:
A23K 1/16, A23K 1/18, A61K 9/42, A61K 31/198, A61K 45/00, A61K 47/12, A61K 47/42, A61P 1/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13816684

ORGANIC-INORGANIC COMPLEX, AND FORMING COMPOSITION THEREOF

IPC classification:
B32B 9/00, C07F 7/18, C08K 5/5419, C08L 83/04, C08L 101/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13819250

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

IPC classification:
A61K 9/127
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13820351

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

IPC classification:
A61K 9/127
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13831167

TREATMENT OF SICKLE CELL DISEASE AND INFLAMMATORY CONDITIONS

IPC classification:
A61K 31/7004, A61K 31/7024, A61K 31/7048, A61P 3/00, A61P 7/00
Applicant:
Regents of the University of Minnesota
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13759274

FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE

IPC classification:
A61K 31/427, A61K 31/4439, A61P 35/00, C07D 413/10, C07D 417/10, C07D 417/14
Applicant:
The Institute of Cancer Research - Royal Cancer Hospital
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13833806

EXTRACTION METHOD

IPC classification:
B01D 11/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13834929

PLANT GROWTH ACCELERATOR

IPC classification:
A01N 25/00, A01N 43/653, A01P 21/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13845276

ROD-SHAPED PLANT VIRUS NANOPARTICLES AS IMAGING AGENT PLATFORMS

IPC classification:
A61K 49/06
Applicant:
Case Western Reserve University
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11804267

BIOSECURE GENETICALLY MODIFIED ALGAE

IPC classification:
C12N 1/12
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13849834

MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB

IPC classification:
A61K 38/06, C07D 277/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11748458

TRANS-EPITHELIAL OSMOTIC COLLYRIUM FOR THE TREATMENT OF KERATOCONUS

IPC classification:
A61K 9/08, A61K 31/14, A61K 31/525, A61P 27/02
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION REFUSED
EP11751155

METHODS FOR SCREENING ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/00
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11768603

NOVEL COPOLYMER

IPC classification:
B01F 17/00, C08F 297/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12744261

SUGAR EXTRACTS

IPC classification:
A23K 1/02, A23K 1/16, A23K 1/18, A23L 1/29, A23L 1/30, A23L 1/307, A61P 3/04, C13K 13/00
Agent:
Stéphane Agasse, Cabinet Germain & Maureau
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14789349

METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC)

IPC classification:
C07D 279/18
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14802705

SELECTIVE GLUCOCORTICOID RECEPTOR LIGANDS

IPC classification:
A61K 31/56, A61K 31/58, A61P 5/44, C07J 41/00, C07J 43/00
Applicant:
University of Manchester
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13171810

Alkylated heterocyclic reaction products useful as antioxidants

IPC classification:
C07C 39/16, C07C 213/08, C07C 215/74, C07D 307/42, C07D 333/16, C07D 333/18, C08K 5/13, C08K 5/18, C08K 5/3415, C08K 5/47, C10M 129/20, C10M 135/34, C10M 149/14, C10M 159/12
Applicant:
Albemarle Corporation
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15743124

METHODS OF TREATING AND IMAGING TUMOR MICROMETASTASES USING PHOTOACTIVATABLE IMMUNOCONJUGATES

IPC classification:
A61K 41/00, A61K 49/00, G01J 1/48
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15174121

PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER

IPC classification:
A61K 49/00, A61K 49/10
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15766414

QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINS

IPC classification:
A61K 31/4704, A61P 35/00, C07D 215/36, C07D 215/38
Applicant:
UCL Business plc
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
Request for examination was made
EP15839387

CRYSTAL POLYMORPHISM OF INCLUSION COMPOUND AND METHOD FOR PRODUCING SAME, AND CURABLE RESIN COMPOSITION

IPC classification:
C07C 37/84, C07C 39/15, C07D 233/64, C08G 59/40, C08G 59/62
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature